CD274 and neoplasm: Tumor-derived mTGOs treated with GANT61 showed decreased expression of not only PD-L1 (Figure 3I), but also proliferating EdU-positive cells (Figure 3I, 3J) at concentration of 5 and 10 μM of the inhibitor compared to the vehicle control (0 μM).